Merck has submitted data on its COVID-19 pill to the FDA after a successful trial; air, land, and ferry travelers will be allowed into the United States in November if they show proof of vaccination; 13 of 33 certified community behavioral health clinics in Michigan will be reimbursed by Medicaid.
An independent FDA advisory panel endorses Moderna boosters for select groups; circuit court lets Texas abortion law stand, paving the way for appeals; Robert Califf, MD, is reportedly being eyed to head the FDA again.
A federal judge denied a bid to stall the implementation of Purdue Pharma’s bankruptcy plan; Social Security checks are expected to increase in 2022; the FDA has released guidelines for the food industry aimed at lowering sodium levels.
DOJ requests federal appeals court to block grant of stay for Texas' abortion law; common synthetic chemicals linked with premature death; influenza hospitalization and death more likely in pediatric minority populations.
Environmental Protection Agency (EPA) to announce plan on strengthening regulations against certain chemicals; risk of emergency complications increased in pregnant women with symptomatic COVID-19; fully vaccinated, heavy marijuana users with substance abuse disorder linked with higher susceptibility to breakthrough infection.